Table 1.
The baseline characteristics of the study population.
| Normal (n = 16) | IDA-pre. Tx. (n = 15) | IDA post. Tx. (n = 10) | Normal Reference Value | |
|---|---|---|---|---|
| Age (years) | 29.25 ± 7.1 | 37.13 ± 7.92 | ||
| Height (cm) | 161.59 ± 3.85 | 161.31 ± 3.48 | ||
| WBC (/µL) | 6793.75 ± 1614.3 | 5046.67 ± 1374.7 | 5440 ± 1734.74 | 4000–10,000 |
| Hemoglobin (g/dl) | 13.43 ± 0.77 | 8.57 ± 1.26 * | 13.31 ± 0.75 | 12–16 |
| Hematocrit (%) | 40.11 ± 1.93 | 28.11 ± 3.33 * | 39.85 ± 2.54 | 36–48 |
| MCV (fl) | 92.52 ± 3.82 | 67.93 ± 7.01 * | 89.19 ± 5.72 | 86–102 |
| RDW (%) | 14.59 ± 4.61 | 19.44 ± 3.45 * | 13.91 ± 1.14 | 11.5–14.5 |
| Platelet (103/µL) | 247.94 ± 45.86 | 344.93 ± 95.67 | 297.5 ± 83.64 | 130–450 |
| Ferritin (ng/mL) | 49.55 (32.42, 75.75) | 2.31 ± 1.4 * | 60.87 ± 77.28 | 5–204 |
IDA, iron-deficiency anemia; WBC, white blood cells; MCV, mean corpuscular volume; RDW, red cell distribution width; *, p < 0.05. Among the values corresponding to IDA patients, those marked with an asterisk were statistically significant when compared with normal subjects and simultaneously significant when compared with subjects who recovered from IDA following iron supplementation.